Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Anthera Pharmaceuticals Inc

ANTH
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US03674U3005
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 617 832 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
ANTH
21.11.2021 - 28.11.2021

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Address: The Pennzoil Building, Houston, TX, United States, 77002

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

-7 468 USD

Last Quarter

-7 655 USD

Key Figures ANTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -36 402 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -141.96 %
PEG Ratio -0.05
Return On Equity TTM -568.85 %
Wall Street Target Price 3 USD
Revenue TTM
Book Value 0.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -28 494 000 USD
Earnings per share -0.01 USD
Diluted Eps TTM -0.01 USD
Most Recent Quarter I 2018
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ANTH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ANTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:8
Payout Ratio
Last Split Date 01.05.2017
Dividend Date 01.05.2017

Stock Valuation ANTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.2052
Price Book MRQ 0.1131

Financials ANTH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANTH

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 1 428 680
200 Day MA 0.0001 USD
Short Ratio 2.09
Shares Short 2 015 026
Short Percent 8.41 %